{"podcast":{"title":"Squawk Pod","slug":"squawk-pod-254103","podcast_index_feed_id":254103,"rss_url":"https://feeds.simplecast.com/VHAcgaw_","website_url":"https://www.cnbc.com","image_url":"https://image.simplecastcdn.com/images/92728f12-3d53-46b8-9a33-60e9b83ad72d/679bd212-c9e5-4d70-b66c-120c53e50c54/3000x3000/squawk-pod-podcast-cover-art-3000x3000-v05.jpg?aid=rss_feed","author":"CNBC","episode_count":2014,"summary":"Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box”, anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer.","last_synced_at":"2026-07-28T06:22:38.634365+00:00","page_url":"https://stenobird.com/podcast/squawk-pod-254103"},"episode":{"title":"Private Credit Woes & Psychedelic Wins 4/20/26","slug":"private-credit-woes-psychedelic-wins-4-20-26","published_at":"2026-04-20T17:35:03+00:00","page_url":"https://stenobird.com/podcast/squawk-pod-254103/private-credit-woes-psychedelic-wins-4-20-26","show_page_url":"https://stenobird.com/podcast/squawk-pod-254103","url":"https://www.cnbc.com","audio_url":"https://dts.podtrac.com/redirect.mp3/cnbc.simplecastaudio.com/2abef7ca-625f-4c74-9157-968d7da67c81/episodes/51e593d1-b7d7-4954-bc9a-a71ea83fd11b/audio/128/default.mp3?aid=rss_feed&awCollectionId=2abef7ca-625f-4c74-9157-968d7da67c81&awEpisodeId=51e593d1-b7d7-4954-bc9a-a71ea83fd11b&feed=VHAcgaw_","summary":"As concerns mount regarding the health of the private credit ecosystem, Oaktree Capital Management co-chairman Howard Marks offers perspective–and some investing advice–when it comes to private lending. Former FDA Commissioner Dr. Scott Gottlieb discusses Eli Lilly’s deal to expand its cancer treatment pipeline as well as President Trump’s executive order on therapeutic psychedelics. Plus, Kevin Warsh’s Fed Chair nomination hearing is this week, and Anthropic’s Mythos is at work within the NSA, despite being blacklisted by the US government. Steve Liesman 14:36 Howard Marks 23:54 Dr. Scott Gottlieb 41:27 In this episode: Steve Liesman, @steveliesman Andrew Ross Sorkin, @andrewrsorkin Becky Quick, @BeckyQuick Joe Kernen, @JoeSquawk Katie Kramer, @Kramer_Katie","meta_description":"As concerns mount regarding the health of the private credit ecosystem, Oaktree Capital Management co-chairman Howard Marks offers perspective–and some in…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2840,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/squawk-pod-254103/episodes/private-credit-woes-psychedelic-wins-4-20-26/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/squawk-pod-254103/private-credit-woes-psychedelic-wins-4-20-26.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}